PDL BioPharma, Inc. Proceeds from Common Stock Issued
PDL BioPharma, Inc. reported Proceeds from Common Stock Issued of $1.40 million for the 12-month period ending 2009-12-31, per its 10-K filed 2011-03-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2011-03-01
- PDL BioPharma, Inc. proceeds from issuance of common stock for the quarter ending 2009-12-31 was $165.00K.
- PDL BioPharma, Inc. proceeds from issuance of common stock for the quarter ending 2009-09-30 was $981.00K.
- PDL BioPharma, Inc. proceeds from issuance of common stock for fiscal 2009 was $1.40M, a 90.89% decline from fiscal 2008.
- PDL BioPharma, Inc. proceeds from issuance of common stock for fiscal 2008 was $15.39M.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|
| 2009-12-31 | $165.00K derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01 | $1.15M derived: sum of 2 quarters · filed 2011-03-01 | $1.40M 10-K · filed 2011-03-01 | |
| 2009-09-30 | $981.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-09 | $1.24M 10-Q · filed 2010-11-09 | ||
| 2009-06-30 | $256.00K 10-Q · filed 2010-07-29 | |||
| 2008-12-31 | $15.39M 10-K · filed 2011-03-01 |